Inositol (cyclohexane-1,2,3,4,5,6-hexol) is a non-essential nutrient synthesized within the body from glucose and is abundant within spinal fluid. Although inositol exists in the form of 9 distinct stereoisomers, the most abundant format within cellular membranes is myo-inositol, accounting for approximately 95% of free inositol within the body. Myo-inositol was initially isolated by researchers in 1849, …
Hydrafinil (Fluorenol) is an unregulated research chemical originally synthesized by Cephalon Pharmaceuticals (now owned by Teva) as a eugeroic (wakefulness-promoting agent). After its synthesis, fluorenol was one of several agents to be considered as a hypothetical successor to the popularized and FDA-approved drug, Provigil (Modafinil). Comparative data from animal trials indicated that fluorenol exhibited ~39% …
Adrafinil (Olmifon) is a eugeroic agent originally synthesized in the 1970s by chemists at Group Lafon, a pharmaceutical company based in France. Following its synthesis, researchers discovered that adrafinil induced wakefulness in humans, and by the mid-1980s, it was being marketed as an experimental treatment for narcolepsy. Though its exact pharmacodynamics aren’t fully elucidated, adrafinil …
Phenibut (brand name “Noofen”) is a neuropsychiatric drug originally synthesized in St. Petersburg, Russia by a team of researchers at the Department of Organic Chemistry of the Herzen Pedagogic Institute. By the 1960s, phenibut was introduced as a pharmaceutical agent in Russia for the treatment of various medical conditions including: anxiety, insomnia, and PTSD. Since …
Noopept (N-phenylacetyl-L-prolylglycine ethyl ester) is a synthetic peptide manufactured in Russia by JSC LEKKO Pharmaceuticals. Chemically, noopept is a hydrophilic proline with a dipeptide structure consisting of a phenylacetyl subunit bound to a small peptide chain of proline and glycine. Although it isn’t technically classified as a “racetam” (due to its lacking of a 2-oxo-pyrrolidine …
Piracetam is a drug that was synthesized in 1964 by Corneliu E. Giurgea et al. at the pharmaceutical company “UCB” headquartered in Belgium. Chemically, it is identified as 2-oxo-1-pyrrolidine acetamide, shares the same base structure with pyroglutamic acid, and as a result of its pyrrolidone nucleus, is classified as a “racetam” compound. Following the synthesis …
Curcumin is considered a diarylheptanoid, or secondary metabolite derived from the plant turmeric (a member of the ginger family). As a diarylheptanoid, curcumin is chemically composed of two aryl groups (aromatic rings) interlinked with a chain of 7 carbon atoms. It was initially discovered by scientists Vogel and Pelletier in 1842 when they extracted and …